Articles producció científica> Medicina i Cirurgia

Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021) [Diabetes mellitus y riesgo cardiovascular: actualización de las recomen

  • Identification data

    Identifier: imarina:9242199
    Authors:
    Arrieta FPedro-Botet JIglesias PObaya JCMontanez LMaldonado GFBecerra ANavarro JPerez JCPetrecca RPardo JLRibalta JSánchez VDuran STébar FJAguilar M
    Abstract:
    This document is an update to the clinical practice recommendations for the management of cardiovascular risk factors (CVRF) in diabetes mellitus. The consensus has been developed by a multidisciplinary team made up of members of the Cardiovascular Risk Group of the Spanish Diabetes Society (SED). The work is a necessary update as, since the last review three years ago, there have been many clinical trials that have studied the cardiovascular outcomes of numerous drugs in the diabetic population. We believe that this guideline update may be of interest to all clinicians treating patients with diabetes. © 2021 Sociedad Española de Arteriosclerosis
  • Others:

    Author, as appears in the article.: Arrieta F; Pedro-Botet J; Iglesias P; Obaya JC; Montanez L; Maldonado GF; Becerra A; Navarro J; Perez JC; Petrecca R; Pardo JL; Ribalta J; Sánchez V; Duran S; Tébar FJ; Aguilar M
    Department: Medicina i Cirurgia
    URV's Author/s: Ribalta Vives, Josep
    Keywords: Obesity Hypertension Dyslipidaemia Diabetes mellitus Consensus Chronic complications Cardiovascular risk factors Age
    Abstract: This document is an update to the clinical practice recommendations for the management of cardiovascular risk factors (CVRF) in diabetes mellitus. The consensus has been developed by a multidisciplinary team made up of members of the Cardiovascular Risk Group of the Spanish Diabetes Society (SED). The work is a necessary update as, since the last review three years ago, there have been many clinical trials that have studied the cardiovascular outcomes of numerous drugs in the diabetic population. We believe that this guideline update may be of interest to all clinicians treating patients with diabetes. © 2021 Sociedad Española de Arteriosclerosis
    Thematic Areas: Pharmacology (medical) Peripheral vascular disease Medicina iii Medicina i Cardiology and cardiovascular medicine
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: josep.ribalta@urv.cat
    Author identifier: 0000-0002-8879-4719
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/submittedVersion
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Clinica E Investigacion En Arteriosclerosis. 34 (1): 36-55
    APA: Arrieta F; Pedro-Botet J; Iglesias P; Obaya JC; Montanez L; Maldonado GF; Becerra A; Navarro J; Perez JC; Petrecca R; Pardo JL; Ribalta J; Sánchez V; (2022). Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021) [Diabetes mellitus y riesgo cardiovascular: actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2021)]. Clinica E Investigacion En Arteriosclerosis, 34(1), 36-55. DOI: 10.1016/j.arteri.2021.05.002
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2022
    Publication Type: Journal Publications
  • Keywords:

    Cardiology and Cardiovascular Medicine,Peripheral Vascular Disease,Pharmacology (Medical)
    Obesity
    Hypertension
    Dyslipidaemia
    Diabetes mellitus
    Consensus
    Chronic complications
    Cardiovascular risk factors
    Age
    Pharmacology (medical)
    Peripheral vascular disease
    Medicina iii
    Medicina i
    Cardiology and cardiovascular medicine
  • Documents:

  • Cerca a google

    Search to google scholar